BE645366A - - Google Patents

Info

Publication number
BE645366A
BE645366A BE645366DA BE645366A BE 645366 A BE645366 A BE 645366A BE 645366D A BE645366D A BE 645366DA BE 645366 A BE645366 A BE 645366A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE645366A publication Critical patent/BE645366A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
BE645366D 1963-03-28 1964-03-18 BE645366A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929519A FR1363948A (fr) 1963-03-28 1963-03-28 Nouvelles bases azotées substituées par au moins un radical naphtyle ou naphtylméthyle

Publications (1)

Publication Number Publication Date
BE645366A true BE645366A (fr) 1964-09-18

Family

ID=8800292

Family Applications (1)

Application Number Title Priority Date Filing Date
BE645366D BE645366A (fr) 1963-03-28 1964-03-18

Country Status (13)

Country Link
US (1) US3334096A (fr)
AT (2) AT247309B (fr)
BE (1) BE645366A (fr)
BR (1) BR6457920D0 (fr)
CH (1) CH483395A (fr)
DE (2) DE1493920C3 (fr)
DK (2) DK125702B (fr)
ES (1) ES298057A1 (fr)
FR (1) FR1363948A (fr)
GB (3) GB1022034A (fr)
NL (5) NL142872B (fr)
NO (1) NO117982B (fr)
SE (2) SE335351B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458529A (en) * 1964-06-10 1969-07-29 Lipha Nitrogenous bases substituted by at least one naphthyl or naphthylmethyl radical
FR5671M (fr) * 1965-04-23 1968-01-02
US3896157A (en) * 1967-01-13 1975-07-22 Syntex Corp Dihydo 2-naphthylacetic acid derivatives
US4048330A (en) * 1967-01-13 1977-09-13 Syntex Corporation Compositions containing 2-(6'-substituted-2'-naphthyl)acetic acid esters used for treating inflammation, pain or pyrexia
US3973033A (en) * 1971-07-29 1976-08-03 Lipha, Lyonnaise Industrielle Pharmaceutique Compositions and methods for producing a vasodilatory effect with a naphthyl tetrahydrofurfuryl amino-ester
FR2146981B1 (fr) * 1971-07-29 1974-09-06 Lipha
US3975390A (en) * 1973-07-26 1976-08-17 Richter Gedeon Vegyeszeti Gyar Rt. N-methyl substituted piperazino nitrobenzophenones and a process for the preparation thereof
FR2371197A1 (fr) * 1976-11-18 1978-06-16 Bottu Nouveaux derives de l'acide isobutyrique disubstitue ainsi que leur application comme medicaments
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
HU177876B (en) * 1979-04-24 1982-01-28 Nitrokemia Ipartelepek Process for preparing 2,6-dialkyl-n-/alkoxy-methyl/-chloro-acetanilide derivatives
FR2505836A1 (fr) * 1981-05-14 1982-11-19 Sanofi Sa Citrate de naftidrofuryl et son application therapeutique
FR2580502B1 (fr) * 1985-04-23 1988-07-08 Lipha Emploi du " naftidrofuryl " dans la preparation d'un medicament
JPH0662521B2 (ja) * 1988-02-24 1994-08-17 日東紡績株式会社 新規コリン誘導体及びそれを用いた血清コリンエステラーゼ活性測定法
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
JP7128969B2 (ja) 2019-01-18 2022-08-31 アストラゼネカ・アクチエボラーグ Ｐｃｓｋ９阻害剤及びその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2417208A (en) * 1943-08-04 1947-03-11 Geigy Ag J R Basic esters of monoalkyl isobutyl acetic acids
CH396872A (de) * 1959-08-13 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Harnstoffe
US3242174A (en) * 1962-02-06 1966-03-22 Pfizer & Co C 1-(tertiary aminosulfonyl)-3-(hydrocarbon) ureas

Also Published As

Publication number Publication date
ES298057A1 (es) 1964-06-01
FR1363948A (fr) 1964-06-19
AT247309B (de) 1966-06-10
NL7400839A (fr) 1974-04-25
US3334096A (en) 1967-08-01
DE1543741A1 (de) 1969-12-11
SE335351B (fr) 1971-05-24
NL7400837A (fr) 1974-04-25
DE1493920C3 (de) 1974-01-17
SE306747B (fr) 1968-12-09
GB1022032A (en) 1966-03-09
DE1543741C3 (de) 1974-02-07
CH483395A (fr) 1969-12-31
NL6403315A (fr) 1964-09-29
DK125702B (da) 1973-03-26
NO117982B (fr) 1969-10-20
GB1022034A (en) 1966-03-09
NL142872C (fr)
DE1493920B2 (de) 1973-06-20
GB1022033A (en) 1966-03-09
BR6457920D0 (pt) 1973-02-22
NL7400838A (fr) 1974-04-25
DK118773B (da) 1970-10-05
DE1543741B2 (de) 1973-07-05
AT250339B (de) 1966-11-10
DE1493920A1 (de) 1969-07-10
NL142872B (nl) 1974-08-15

Similar Documents

Publication Publication Date Title
BE627012A (fr)
BE627025A (fr)
BE645798A (fr)
BE645311A (fr)
BE645252A (fr)
BE644629A (fr)
BE644209A (fr)
BE582314A (fr)
BE643777A (fr)
BE547422A (fr)
NL7400838A (fr)
BE643319A (fr)
BE643179A (fr)
BE641920A (fr)
BE634606A (fr)
BE629853A (fr)
BE627172A (fr)
BE627151A (fr)
BE627145A (fr)
BE627141A (fr)
BE627083A (fr)
BE627023A (fr)
BE626986A (fr)
BE626938A (fr)
BE626915A (fr)